Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1676
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2490
    -0.0021 (-0.16%)
     
  • Bitcoin GBP

    50,969.75
    -751.80 (-1.45%)
     
  • CMC Crypto 200

    1,325.46
    -71.08 (-5.09%)
     
  • S&P 500

    5,110.19
    +61.77 (+1.22%)
     
  • DOW

    38,302.03
    +216.23 (+0.57%)
     
  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     
  • GOLD FUTURES

    2,347.40
    +4.90 (+0.21%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Top Ranked Momentum Stocks to Buy for January 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:

Apple Inc. (AAPL): This designer and manufacturer of smartphones, personal computers, tablets, wearables and accessories has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

Apple Inc. Price and Consensus

Apple Inc. Price and Consensus
Apple Inc. Price and Consensus

Apple Inc. price-consensus-chart | Apple Inc. Quote

Apple's shares gained 12.2% over the last one month compared to S&P 500’s rise of 3.3%. The company possesses a Momentum Score of A.

ADVERTISEMENT

Apple Inc. Price

Apple Inc. Price
Apple Inc. Price

Apple Inc. price | Apple Inc. Quote

Addus HomeCare Corporation (ADUS): This provider of comprehensive home care services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Addus HomeCare Corporation Price and Consensus

Addus HomeCare Corporation Price and Consensus
Addus HomeCare Corporation Price and Consensus

Addus HomeCare Corporation price-consensus-chart | Addus HomeCare Corporation Quote

Addus HomeCare’s shares gained 5.7% over the last one month. The company possesses a Momentum Score of A.

Addus HomeCare Corporation Price

Addus HomeCare Corporation Price
Addus HomeCare Corporation Price

Addus HomeCare Corporation price | Addus HomeCare Corporation Quote

Bristol-Myers Squibb Company (BMY): This manufacturer and distributor of biopharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.2% over the last 60 days.

Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company Price and Consensus
Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote

Bristol-Myers’ shares gained 5.6% over the last one month. The company possesses a Momentum Score of A.

Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company Price
Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company price | Bristol-Myers Squibb Company Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
 
Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.